Staar Surgical Shareholders Block $1.6B Alcon Acquisition Deal
Staar Surgical shareholders reject Alcon's $1.6 billion takeover bid after activist investor campaign. Company to remain independent on Nasdaq.
/ 2 items
Staar Surgical shareholders reject Alcon's $1.6 billion takeover bid after activist investor campaign. Company to remain independent on Nasdaq.
Alcon boosts its bid for Staar Surgical to $30.75 per share, valuing the company at $1.6 billion. The updated offer adds $150M in equity value and aims to secure shareholder approval after months of resistance.